Although the ORs for the risk of delayed bleeding for dabigatran, compared with rivaroxaban (0.49), and rivaroxaban, compared with edoxaban (0.79), were similar to those in the main analysis, these comparisons did not reach statistical significance after correction for multiple testing.
← all excerpts
Optimal direct oral anticoagulant for upper gastrointestinal endoscopic submucosal dissection.
1
—
—